Immatics at the CAR-TCR Summit Europe (Feb 25-27) in London, UK

| News, USA

Immatics will attend the CAR-TCR Summit (Feb 25-27) in London, UK! If you are interested in Immatics' role to deliver safe and effective cancer immunotherapies approach Harpreet Singh (CEO Immatics US):


Monday, February 25

2pm - 4pm

Workshop A: "Discovery of Novel Targets and T-Cell Receptors for Cancer Immunotherapies"


Wednesday, February 27

1.30pm - 2pm

Talk: "Personalized T-Cell Therapies to Target Novel Solid Tumor Antigens"


We’re looking forward to interesting and exciting discussions.

Further information on the CAR-TCR Summit Europe here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.